Norman Asher Brooks
Physician at Marbro Dr, Van Nuys, CA

License number
Colorado 16727
Issued Date
Oct 13, 1970
Renew Date
Dec 31, 1978
Expiration Date
Dec 31, 1978
Type
Physician
Address
Address
16420 Marbro Dr, Van Nuys, CA 91316

Professional information

Norman A Brooks Photo 1

Dr. Norman A Brooks, Encino CA - MD (Doctor of Medicine)

Specialties:
Dermatopathology
Address:
Skin Cancer Medical Center
16311 Ventura Blvd STE 690, Encino 91436
(818) 907-8144 (Phone)
Certifications:
Dermatology, 1977, Dermatopathology, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Skin Cancer Medical Center
16311 Ventura Blvd STE 690, Encino 91436
Mission Community Hospital - Panorama
14850 Roscoe Blvd, Panorama City 91402
Providence Tarzana Medical Center
18321 Clark St, Tarzana 91356
Education:
Medical School
University Of Colorado School Of Medicine
Graduated: 1969
University Wisc Hospital
Graduated: 1970
UCLA Med Center
Graduated: 1976
University Colo Hospital
Graduated: 1972
University Of California Los Angeles
University Of Wisconsin Madison


Norman Asher Brooks Photo 2

Norman Asher Brooks, Encino CA

Specialties:
Dermatologist
Address:
16311 Ventura Blvd, Encino, CA 91436
Education:
University of Colorado, School of Medicine (Denver) - Doctor of Medicine*
University of Wisconsin Hospital & Clinics - Fellowship - Chemotherapy Surgery*
Ronald Reagan UCLA Medical Center - Residency - Dermatology*
University of Colorado Hospital-Anschutz Inpatient Pavilion - Residency - Internal Medicine*
Ronald Reagan UCLA Medical Center - Residency - Dermatopathology (Dermatology and Pathology)*
Board certifications:
American Board of Dermatology Certification in Dermatology*, American Board of Dermatology Sub-certificate in Dermatopathology (Dermatology)*


Norman Brooks Photo 3

Zinc Chloride Unit Dose Packaging, Applicator, And Method Of Use In Treating Cancer And Other Skin Diseases

US Patent:
6558694, May 6, 2003
Filed:
Feb 16, 2000
Appl. No.:
09/505618
Inventors:
Norman A. Brooks - Encino CA 91436
Leslee S. Brooks - Encino CA 91436
International Classification:
A61K 1300
US Classification:
424449, 424443, 424484, 424485, 424486, 424487, 424488, 424 7803, 424448
Abstract:
An improved method for the treatment of melanoma and skin diseases which utilizes a zinc chloride fixative mixture is provided. The active ingredients of the fixative mixture include zinc chloride (a deeply penetrating, tissue killing histologic preservative), and the anti-cancer plant alkaloids sanguinarine and chelerythrine. Zinc chloride allows the surgeon to perform a complete conventional surgical excision around and below a melanomatous tumor through painless, bloodless dead tissue, and because the microscopic structures are fixed in place by the zinc chloride, the excised tissue can be examined by a pathologist to confirm complete excision and clearance of the melanoma. Although zinc chloride fixative paste has been shown to be an effective treatment for human skin cancer and melanoma, this treatment has been overlooked by the medical community. The paste is difficult to maintain and complicated to apply to the affected skin. This invention allows the active ingredients of zinc chloride fixative paste to be effectively administered to the skin by providing single-use dose specific storage, application, dressing, and administration systems needed to facilitate the use of topical zinc chloride mixtures and/or zinc chloride pastes in the treatment of melanoma and other skin diseases.


Norman Brooks Photo 4

Zinc Chloride Composition, Unit Dose Packaging, Applicator, And Method Of Use In Treating Cancer And Other Skin Diseases

US Patent:
2002015, Oct 17, 2002
Filed:
Jun 12, 2002
Appl. No.:
10/171326
Inventors:
Norman Brooks - Encino CA, US
Leslee Brooks - Encino CA, US
International Classification:
A61K035/78, A61K033/32, A61K031/337
US Classification:
424/643000, 424/749000, 424/770000, 514/449000
Abstract:
An improved method for the treatment of melanoma and skin tumors which utilizes a zinc chloride composition is provided. The zinc chloride composition allows the surgeon to obtain hemostasis after a biopsy, and to incise or excise a melanomatous or other skin tumor through painless, bloodless, dead tissue. Because the microscopic structures are fixed in place by the zinc chloride, excised tissue can be examined microscopically by a pathologist. This invention allows the active ingredients of zinc chloride compositions to be effectively administered to the skin by providing single-use dose specific storage, application, dressing, and administration systems needed to facilitate the use of the topical zinc chloride mixtures. Enhanced zinc chloride mixture formulations including herbal taxoids are described.